• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome.

作者信息

White R H, Cameron J S, Trounce J R

出版信息

Br Med J. 1966 Oct 8;2(5518):853-60. doi: 10.1136/bmj.2.5518.853.

DOI:10.1136/bmj.2.5518.853
PMID:5917404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1944072/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/c81e46e25943/brmedj02362-0040-f.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/65f1774ea501/brmedj02362-0037-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/6ac3438b7fd8/brmedj02362-0037-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/b2fa18398b2f/brmedj02362-0039-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/b1cc2241a905/brmedj02362-0039-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/be5601a07972/brmedj02362-0039-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/a770699aae8d/brmedj02362-0039-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/e767584655b6/brmedj02362-0039-e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/a9169ce2e21b/brmedj02362-0039-f.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/2e91d097b708/brmedj02362-0038-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/2675df3286af/brmedj02362-0040-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/8d80ad0b5019/brmedj02362-0040-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/edcd0b6327c1/brmedj02362-0040-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/9fcc3155d3c2/brmedj02362-0040-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/fd55c68d8d1d/brmedj02362-0040-e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/c81e46e25943/brmedj02362-0040-f.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/65f1774ea501/brmedj02362-0037-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/6ac3438b7fd8/brmedj02362-0037-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/b2fa18398b2f/brmedj02362-0039-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/b1cc2241a905/brmedj02362-0039-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/be5601a07972/brmedj02362-0039-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/a770699aae8d/brmedj02362-0039-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/e767584655b6/brmedj02362-0039-e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/a9169ce2e21b/brmedj02362-0039-f.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/2e91d097b708/brmedj02362-0038-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/2675df3286af/brmedj02362-0040-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/8d80ad0b5019/brmedj02362-0040-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/edcd0b6327c1/brmedj02362-0040-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/9fcc3155d3c2/brmedj02362-0040-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/fd55c68d8d1d/brmedj02362-0040-e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c278/1944072/c81e46e25943/brmedj02362-0040-f.jpg

相似文献

1
Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome.伴有肾病综合征的类固醇抵抗性增殖性肾小球肾炎的免疫抑制治疗
Br Med J. 1966 Oct 8;2(5518):853-60. doi: 10.1136/bmj.2.5518.853.
2
[Correlations between the histological changes and results of treatment with corticoids and immunosuppressive agents in primary glomerulonephritis].[原发性肾小球肾炎的组织学改变与皮质类固醇及免疫抑制剂治疗结果的相关性]
Minerva Med. 1970 Jul 11;61(55):3054-63.
3
[Therapy of glomerulonephritis with corticosteroids and immunosuppressive agents].[用皮质类固醇和免疫抑制剂治疗肾小球肾炎]
Dtsch Med Wochenschr. 1974 May 24;99(21):1151-6. doi: 10.1055/s-0028-1107909.
4
Management of the nephrotic syndrome.
Clin Pediatr (Phila). 1974 Jan;13(1):45-51. doi: 10.1177/000992287401300105.
5
Cytotoxic drugs in steroid-resistant renal disease. Alkylating and antimetabolic agents in the treatment of nephrotic syndrome, lupus nephritis, chronic glomerulonephritis, and purpura nephritis in children.
Am J Dis Child. 1966 Nov;112(5):448-58. doi: 10.1001/archpedi.1966.02090140120011.
6
Cyclophosphamide in the treatment of glomerulonephritis.环磷酰胺治疗肾小球肾炎
Prog Biochem Pharmacol. 1974;9:65-81.
7
Corticosteroid and immunosuppressive therapy of idiopathic nephrotic syndrome.特发性肾病综合征的皮质类固醇和免疫抑制治疗
J Okla State Med Assoc. 1971 Nov;64(11):448-54.
8
[Familial nephrotic syndrome].
Monatsschr Kinderheilkd (1902). 1970 Jun;118(6):328-30.
9
Immunosuppressive therapy. 2.免疫抑制疗法。2.
N Engl J Med. 1972 Aug 10;287(6):281-6. doi: 10.1056/NEJM197208102870606.
10
[Immunosuppressive treatment of glomerulonephritis and nephrotic syndrome].[肾小球肾炎和肾病综合征的免疫抑制治疗]
Med Glas. 1971 Jul-Aug;25(7):273-6.

引用本文的文献

1
Cytotoxic drug therapy in steroid-resistant glomerulonephritis.类固醇抵抗性肾小球肾炎的细胞毒性药物治疗
Proc R Soc Med. 1967 Nov 1;60(11 Part 1):1164-8. doi: 10.1177/003591576706011P144.
2
Immunosupressive or anti-inflammatory?免疫抑制还是抗炎？
Br Med J. 1967 Mar 18;1(5541):650-1.
3
Management of the nephrotic syndrome due to primary renal disease.原发性肾病所致肾病综合征的管理

本文引用的文献

1
Treatment of the nephrotic syndrome with nitrogen mustard.
J Lab Clin Med. 1950 Dec;36(6):996-7.
2
[Trial treatment of various glomerular nephropathies with nitrogen mustards].[用氮芥对各种肾小球肾病进行试验性治疗]
Sem Hop Ther Paris. 1962 May;38:425-30.
3
IMMUNOLOGIC BASIS OF RENAL DISEASE.肾脏疾病的免疫学基础
Pediatr Clin North Am. 1964 Aug;11:685-721. doi: 10.1016/s0031-3955(16)31590-5.
Can Med Assoc J. 1967 Jan 7;96(1):52-3.
4
Cyclophosphamide therapy in the nephrotic syndrome in childhood.儿童肾病综合征的环磷酰胺治疗
Br Med J. 1969 Mar 15;1(5645):666-71. doi: 10.1136/bmj.1.5645.666.
5
Cyclophosphamide for nephrotic syndrome in children.环磷酰胺用于儿童肾病综合征
Br Med J. 1969 Mar 15;1(5645):660-1. doi: 10.1136/bmj.1.5645.660-a.
6
Prognosis of the nephrotic syndrome.肾病综合征的预后。
Br Med J. 1968 Nov 9;4(5627):343-4.
7
Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings.环磷酰胺在儿童肾病综合征中的应用：根据临床、光镜及免疫病理结果对两组患者的应用情况
Can Med Assoc J. 1968 Mar 16;98(11):524-31.
8
The mode of action of cytotoxic drugs.细胞毒性药物的作用方式。
Proc R Soc Med. 1970 Oct;63(10):1063-6. doi: 10.1177/003591577006301050.
9
Antilymphocyte serum and glomerulonephritis.抗淋巴细胞血清与肾小球肾炎
Br Med J. 1970 Apr 4;2(5700):4-5. doi: 10.1136/bmj.2.5700.4.
10
Mercaptopurine-dependent remission of nephrotic syndrome.巯嘌呤依赖的肾病综合征缓解
Br Med J. 1970 Jun 13;2(5710):645-6. doi: 10.1136/bmj.2.5710.645.
4
THE BETA-1C GLOBULIN IN CHILDHOOD NEPHROTIC SYNDROME: LABORATORY DIAGNOSIS OF PROGRESSIVE GLOMERULONEPHRITIS.儿童肾病综合征中的β-1C球蛋白：进行性肾小球肾炎的实验室诊断
N Engl J Med. 1965 Sep 2;273:524-9. doi: 10.1056/NEJM196509022731004.
5
[IMMUNOSUPPRESSIVE CHEMOTHERAPY OF NEPHROTIC SYNDROMES AND CERTAIN TYPES OF GLOMERULONEPHRITIS].[肾病综合征及某些类型肾小球肾炎的免疫抑制化疗]
Bull Acad Natl Med. 1965 Mar 30;149:259-63.
6
IMMUNOSUPPRESSIVE AGENTS.免疫抑制剂。
Br Med Bull. 1965 May;21:140-6. doi: 10.1093/oxfordjournals.bmb.a070382.
7
SELECTIVITY OF PROTEIN EXCRETION IN PATIENTS WITH THE NEPHROTIC SYNDROME.肾病综合征患者蛋白质排泄的选择性
J Clin Invest. 1964 Dec;43(12):2332-46. doi: 10.1172/JCI105107.
8
THIOGUANINE IN THE TREATMENT OF CERTAIN AUTOIMMUNE, IMMUNOLOGIC AND RELATED DISEASES.硫鸟嘌呤在某些自身免疫性、免疫性及相关疾病治疗中的应用
Am J Med. 1964 Aug;37:195-205. doi: 10.1016/0002-9343(64)90005-1.
9
[TREATMENT OF NEPHROTIC SYNDROMES IN ADULT AFRICANS WITH CYCLOPHOSPHAMIDE].
Therapie. 1964 Jul-Aug;19:921-7.
10
ACUTE ANURIC GLOMERULONEPHRITIS.急性无尿性肾小球肾炎
Q J Med. 1964 Jan;33:105-15.